Home

Juliette Berangere Audet, Chief Business Officer: NewAmsterdam Pharma NAMS Buy · Filed 24/09/30

Trade details

Type
Insider buy
Amount
$17,332.8
Shares · price
1,104 sh · $15.70 a share
Held after
1,104 sh
Trade date
24/09/26
Filed
24/09/30
Days to filing
4 days

First buy since 2023

Insiders buying this week
1 insiders

NewAmsterdam Pharma trades, last 26 weeks

What else happened in NewAmsterdam Pharma around then

Filed or reported within 30 days of the trade day · 24/08/27~24/10/26

Juliette Berangere Audet's recent trades

No other trades yet.